July 28, 2021

Hardwood Paroxysm

All Latest News For You!

The number of COVID cases in the United States begins to stagnate | Corona virus

The number of new cases has stagnated since mid-June, when the first detected and highly contagious delta variant in India quickly became the dominant variant in the United States, replacing the alpha variant that appeared in the United States. United.

It currently represents about 35% of cases in the United States, up from about 10% last week. Public health experts warned that delta variability could occur Rise of epidemics among unaffected populations, especially in the south of the countryThus creating a new threat.

Since June 16, the number of new infections diagnosed each day in the United States has fluctuated between 11,000 and 12,000 cases or 3.5 cases per 100,000 people.

The difference between high-vaccinated areas, especially in the northeastern United States, and low-lying areas, including the southern states of the country, is somehow obvious.

For example, in Burlington, Vermont area, nearly 74% of the population has received at least one dose of the vaccine, with only 0.5 new cases per 100,000 population, according to data from COVID ActNow, an independent organization that treats infections.

In contrast, in Missouri, where at least 45% of the population is partially vaccinated, the Springfield area faces 36.6 new cases per 100,000 population.

According to data compiled by the Mayo Clinic, a nonprofit educational center in the United States, the full vaccination rate is over 50% in 20 states, including the District of Columbia.

A complete vaccine is equivalent to two doses of Pfizer-Bioentech or Modern vaccines or one dose of the Johnson & Johnson vaccine.

READ  United Kingdom: 60% more infected, delta variation continues its rise

With a full vaccination rate of 65%, Vermont leads. Next are Massachusetts (61%), Maine (60.7%), Connecticut (60%) and Rhode Island (58.3%), located in the northeastern United States, where the vaccine is particularly effective in rural areas. It has eight of the ten states with the highest vaccination rates.

State vaccination rates also reveal a discriminatory divide.

All 20 states with the highest rates of full vaccination voted for Joe Biden in the November 2020 presidential election.

In contrast, 17 out of 20 states, mostly southern states, voted for Donald Trump in vaccination.

In Mississippi, only 29.3% of citizens received all doses of their vaccine. Alabama, Arkansas, Louisiana and Wyoming have rates of 32.3%, 33.9%, 34.3% and 34.1%, respectively.

Nationwide, 46% of Americans received all doses of their vaccine, and 54% received at least one injection, according to official data.

Missed target

Last week, the White House agreedVaccination target set by Joe Biden on July 4th, American Independence Day, will not be achieved.

In early May, the U.S. president aimed to give at least one dose to 70% of American adults during National Day celebrations, hoping something will return to normal by this index date.

A few weeks ago, he started one National Action Month, Revelation a All-out strategy To convince Americans to get vaccinated.

From mid-April to early June the number of cases across the country fell sharply, which coincided with the spring and the increase in outdoor activities. In mid-May, there was a corona virus Retreated in all American states for the first time.

READ  Former United States Secretary of Defense Donald Rumsfeld has died

However, the summer heat has brought more people into the home, where airborne disease is mainly contagious. By air-drying, air conditioning – estimated by many Americans – makes the conditions for the virus to spread more favorable.

These are all sources of concern for unknown people.

According to official English data, two weeks after the second dose, the Pfizer-Bioendech vaccine is 88% effective against the symptomatic form of COVID-19 caused by delta variation.

A study in the UK concluded that the Pfizer-Bioendech vaccine was a single dose four weeks after the first dose of AstraZeneca-Oxford A much stronger immune response than two doses of AstraZeneca.